SINTX ups CEO Olson's severance to 2x salary, adds CSO Honigblum change-of-control deal

Sintx Technologies, Inc.

CEO Eric Olson's severance multiplier raised from 1x to 2x highest annual salary in prior three years.
CSO Gregg Honigblum gets new Change of Control Agreement with 2x salary severance plus 12 months health coverage.
Both agreements provide full equity vesting upon change in control and gross-up for excise taxes under Section 4999.
Changes effective December 12, 2024; Olson's amendment and Honigblum's new agreement detailed in filing.

item 5.02

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-24-049998
form_type: 8-K
ticker: SINT
cik: 0001269026
company_name: Sintx Technologies, Inc.
filed_at: 2024-12-13T23:59:59+00:00
discovered_at: 2026-05-14T18:03:07.936714+00:00
generated_at: 2026-05-29T03:20:20.657738+00:00
sec_items: ["5.02"]
event_type: other
sentiment: neutral
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-24-049998
json_url: https://secwatch.observer/filing/0001493152-24-049998.json
markdown_url: https://secwatch.observer/filing/0001493152-24-049998.md
text_url: https://secwatch.observer/filing/0001493152-24-049998.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1269026/000149315224049998/0001493152-24-049998-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1269026/000149315224049998/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

EDSA

Edesa Biotech shareholders approve equity plan amendment adding 750K shares

Edesa Biotech, Inc. May 29, 2026, 4:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02 same event type: other similar materiality

Filing page SEC filing

NBIX

Neurocrine annual meeting re-elects three directors, approves equity plan and auditor

NEUROCRINE BIOSCIENCES INC May 28, 2026, 4:01 PM ET other Items 5.02, 5.07

same SEC item: 5.02 same event type: other similar materiality

Filing page SEC filing

HAFC

Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP

HANMI FINANCIAL CORP May 27, 2026, 6:15 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02 same event type: other similar materiality

Filing page SEC filing

KKR

KKR & Co. re-elects all 11 incumbent directors including Kravis, Roberts, Bae, Nuttall

KKR & Co. Inc. May 29, 2026, 4:16 PM ET other Items 5.02, 5.07

same SEC item: 5.02 same event type: other

Filing page SEC filing

ONDS

Ondas shareholders approve increase in authorized shares to 1.2B and stock plan pool to 81M shares

Ondas Inc. May 28, 2026, 4:09 PM ET other Items 5.02, 5.07, 9.01

same SEC item: 5.02 same event type: other

Filing page SEC filing

TKNO

Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor

Alpha Teknova, Inc. June 1, 2026, 5:22 PM ET leadership Items 5.02, 5.07, 9.01

same SEC item: 5.02 similar materiality

Filing page SEC filing

AEVA

Aeva Tech approves max target bonuses for CEO and President/CTO; CFO gets target

Aeva Technologies, Inc. June 1, 2026, 5:00 PM ET other_material Items 5.02

same SEC item: 5.02 similar materiality

Filing page SEC filing

MZYX

MOZAYYX Acquisition appoints Emma Rose Bienvenu as independent director

MOZAYYX Acquisition Corp. June 1, 2026, 5:00 PM ET leadership Items 5.02

same SEC item: 5.02 similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-24-049998

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.